I don't understand the mentality that if only management were out of the way the science could prevail. B was purchased off the trash heap. Nobody wanted it. A flailing OTC Pink Sheet stock picked it up and sent PR's to Obama to pump the stock up and secure financing to keep the lights on for a few years.
K did have a chance at one point. The odds of it having an impact have diminished to near zero.
Luckily for Menon, he probably found a way to capitalize on K through Aruda. Pretty genius way to do it and the shareholders never asked for a detailed reason that the Aruda settlement came out of nowhere.